Disc Medicine, Inc.
IRON
$-0.22
Change (1 day)
$77.60
Year High
$25.60
Year Low
Categories
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Earnings for Disc Medicine, Inc. (IRON)
Earnings in 2023 (TTM): $-76,330,000
According to Disc Medicine, Inc.'s latest financial reports the company's current earnings (TTM) are $-76,330,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Disc Medicine, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-76,330,000 | $-76,429,000 |
| 2022 | $-46,827,000 | $-46,090,000 |
| 2021 | $-35,969,000 | $-41,005,000 |
| 2020 | $-40,837,000 | $-47,663,000 |